Shanghai Hile Bio-Technology Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 86.71% vs 24.41% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 22.50% vs 102.43% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "88.50",
          "val2": "47.40",
          "chgp": "86.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "20.50",
          "val2": "14.70",
          "chgp": "39.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "0.10",
          "chgp": "700.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.00",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "9.80",
          "val2": "8.00",
          "chgp": "22.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "148.80%",
          "val2": "154.40%",
          "chgp": "-0.56%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -30.44% vs 11.38% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -260.90% vs 263.20% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "185.80",
          "val2": "267.10",
          "chgp": "-30.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "60.10",
          "val2": "55.70",
          "chgp": "7.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.30",
          "val2": "5.50",
          "chgp": "-76.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-633.40",
          "val2": "-13.90",
          "chgp": "-4,456.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-292.20",
          "val2": "181.60",
          "chgp": "-260.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "240.90%",
          "val2": "61.50%",
          "chgp": "17.94%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

88.50

47.40

86.71%

Operating Profit (PBDIT) excl Other Income

20.50

14.70

39.46%

Interest

0.80

0.10

700.00%

Exceptional Items

-2.00

-0.00

Consolidate Net Profit

9.80

8.00

22.50%

Operating Profit Margin (Excl OI)

148.80%

154.40%

-0.56%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is 86.71% vs 24.41% in Mar 2026

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 22.50% vs 102.43% in Mar 2026

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

185.80

267.10

-30.44%

Operating Profit (PBDIT) excl Other Income

60.10

55.70

7.90%

Interest

1.30

5.50

-76.36%

Exceptional Items

-633.40

-13.90

-4,456.83%

Consolidate Net Profit

-292.20

181.60

-260.90%

Operating Profit Margin (Excl OI)

240.90%

61.50%

17.94%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -30.44% vs 11.38% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -260.90% vs 263.20% in Dec 2024

All Annual Results